Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spectral Markers in Aspirin Chemoprevention of Colonic Neoplasia
NCT00468910Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2007
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Mar 2007; status: completed.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00468910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468910.